Art

J-GLOBAL ID：201602245946768265   Reference number：16A1226521

分子遺伝学的診断に基づく髄芽腫の治療法選択

Author (2)： KANEMURA YONEHIRO (独立行政法人国立病院機構大阪医療センター臨床研究センター先進医療研究開発部再生医療研究室) ,  KANEMURA YONEHIRO (独立行政法人国立病院機構大阪医療センター脳神経外科)
Material： 脳神経外科ジャーナル  (Japanese Journal of Neurosurgery)
Volume： 25  Issue： 4  Page： 307-314(J-STAGE)  Publication year： 2016 
JST Material Number： L1466A  ISSN： 0917-950X  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： human ,...
Semi thesaurus term： Treatment selection ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A1226521&from=J-GLOBAL&jstjournalNo=L1466A") }}

Author keywords (6)： medulloblastoma ,  molecular subgroup ,  therapeutic strategy ,  medulloblastoma ,  molecular subgroup ,  therapeutic strategy

JST classification (2)： Tumors(=neoplasms)of nervous system  (GN04000V) ,  Clinical oncology in general  (GE03010Y)

Reference (24)：

• 1) Evans DG, Birch JM, Ramsden RT, Sharif S, Baser ME : Malignant transformation and new primary tumours after therapeutic radiation for benign disease : substantial risks in certain tumour prone syndromes. J Med Genet 43 : 289-294, 2006.
• 2) Faria CC, Agnihotri S, Mack SC, Golbourn BJ, Diaz RJ, Olsen S, Bryant M, Bebenek M, Wang X, Bertrand KC, Kushida M, Head R, Clark I, Dirks P, Smith CA, Taylor MD, Rutka JT : Identification of alsterpaullone as a novel small molecule inhibitor to target group 3 medulloblastoma. Oncotarget 6 : 21718-21729, 2015.
• 3) Felix CA, Hosler MR, Provisor D, Salhany K, Sexsmith EA, Slater DJ, Cheung NK, Winick NJ, Strauss EA, Heyn R, Lange BJ, Malkin D : The p53 gene in pediatric therapy-related leukemia and myelodysplasia. Blood 87 : 4376-4381, 1996.
• 4) Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, Woo S, Wheeler G, Ahern V, Krasin MJ, Fouladi M, Broniscer A, Krance R, Hale GA, Stewart CF, Dauser R, Sanford RA, Fuller C, Lau C, Boyett JM, Wallace D, Gilbertson RJ : Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96) : long-term results from a prospective, multicentre trial. Lancet Oncol 7 : 813-820, 2006.
• 5) Gottardo NG, Hansford JR, McGlade JP, Alvaro F, Ashley DM, Bailey S, Baker DL, Bourdeaut F, Cho YJ, Clay M, Clifford SC, Cohn RJ, Cole CH, Dallas PB, Downie P, Doz F, Ellison DW, Endersby R, Fisher PG, Hassall T, Heath JA, Hii HL, Jones DT, Junckerstorff R, Kellie S, Kool M, Kotecha RS, Lichter P, Laughton SJ, Lee S, McCowage G, Northcott PA, Olson JM, Packer RJ, Pfister SM, Pietsch T, Pizer B, Pomeroy SL, Remke M, Robinson GW, Rutkowski S, Schoep T, Shelat AA, Stewart CF, Sullivan M, Taylor MD, Wainwright B, Walwyn T, Weiss WA, Williamson D, Gajjar A : Medulloblastoma Down Under 2013 : a report from the third annual meeting of the International Medulloblastoma Working Group. Acta Neuropathol 127 : 189-201, 2014.

Terms in the title (4)： 分子遺伝学 ,  診断 ,  髄芽腫 ,  治療法選択